Twist Bioscience Corporation (TWST)

Nasdaq · Healthcare · Biotechnology
$103.32-7.44%As of 2026-11-22 · USD
Last session low $101.00Last session high $108.50
52-week low $28.2752-week high $219.71
Market cap
$7.04B
Sector
Healthcare
Next earnings
2027-02-01 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)37.3In the neutral range (30 to 70)
MACD (12, 26, 9)-11.35Below its signal line (-9.39); histogram -1.97
Bollinger %B (20, 2)17%Inside the bands (89.52 to 172.76)
SMA 20131.14Price is 21.2% below
SMA 50148.56Price is 30.5% below
SMA 20094.83Price is 9.0% above
ATR (20)14.41% of priceAverage true range per day
52-week position39%In the middle of the 28.27 to 219.71 range

About Twist Bioscience Corporation

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products.

Insider filings, 90 daysNo purchases and 25 sales (about $86.4M).
Latest fiscal yearEnded 2026-09-30: revenue of $459.43M and an operating margin of -28.8%.
Next earnings reportExpected on 2027-02-01 (the date is an estimate).

More in Biotechnology